Canada markets open in 14 minutes

IBEX Technologies Inc. (IBT.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.5300+0.0400 (+8.16%)
At close: 09:32AM EDT
Full screen
Previous Close0.4900
Bid0.4500 x 0
Ask0.5300 x 0
Day's Range0.5300 - 0.5300
52 Week Range0.2700 - 0.6000
Avg. Volume12,353
Market Cap13.156M
Beta (5Y Monthly)0.39
PE Ratio (TTM)10.39
EPS (TTM)0.0510
Earnings DateJun 15, 2022 - Jun 20, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire

    IBEX Reports Results for the Second Quarter and the Six Months Ended January 31, 2022

    MONTRÉAL, March 17, 2022 (GLOBE NEWSWIRE) -- IBEX Technologies Inc. (“IBEX” or the “Company”) (TSX Venture: IBT) today reported its financial results for the six months ended January 31, 2022. “We are pleased with the continued growth driven by strong sales of heparinase-based products,” said Paul Baehr, IBEX President & CEO “and with the continued strengthening of the Company’s balance sheet. We foresee the trend to continue for the balance of the fiscal year.” Note: All figures are in Canadian

  • Simply Wall St.

    IBEX Technologies Inc.'s (CVE:IBT) Stock Is Going Strong: Have Financials A Role To Play?

    IBEX Technologies (CVE:IBT) has had a great run on the share market with its stock up by a significant 48% over the...

  • GlobeNewswire

    IBEX Announces Results of Annual Meeting

    MONTREAL, Feb. 17, 2022 (GLOBE NEWSWIRE) -- IBEX Technologies Inc. (“IBEX” or the “Company”) (TSX Venture: IBT) is pleased to announce that all six nominees listed in its management proxy circular dated January 4, 2022 were re-elected as directors at the Company’s annual and special meeting held today in Montreal. At the meeting, shareholders also approved a resolution ratifying, confirming and approving the “reload” of 527,008 common shares under IBEX’s Incentive Stock Option Plan and a resolut